Editorial Policy
Editorial Mission
Pharminsight exists to facilitate informed, evidence-based, and experience-driven discussions across the life sciences ecosystem.
The platform publishes expert perspectives, opinions, white papers, case studies, and translational insights that contribute to scientific, technical, regulatory, manufacturing, business, and policy advancement.
Editorial Independence
Editorial decisions are made independently by the Editorial Board. Acceptance or rejection of content is based solely on quality, accuracy, relevance, originality, and professional conduct.
Editorial decisions are not influenced by sponsorships, advertising, affiliations, or commercial interests.
Content Categories
Pharminsight publishes Perspectives, Opinions, White Papers, Industry Problem Statements, Case Studies, and Expert Commentaries. See the Content Classification & Review Policy for how each is reviewed and labelled.
Review Process
All submissions undergo:
- Editorial Screening
- Expert Review (where applicable)
- Author Revision (if required)
- Copy Editing
- Final Editorial Approval
The extent of review may vary depending on content type.
Accuracy and Evidence
Authors are expected to verify factual statements, use credible references where applicable, and distinguish clearly between evidence and opinion. The Editorial Team may request supporting documentation when necessary.
Corrections and Updates
Pharminsight is committed to maintaining accurate content. Published articles may be corrected, updated, versioned, or (in exceptional circumstances) retracted. Significant modifications will be documented transparently.
Advertising and Sponsored Content
Sponsored content must be clearly identified. Sponsored articles are subject to the same editorial standards as other submissions. Commercial promotion disguised as independent content is not permitted.
Intellectual Property
Authors retain ownership of their work. By submitting content, authors grant Pharminsight the right to publish, archive, distribute, and promote the material.
Editorial Ethics
Pharminsight adheres to principles of transparency, fairness, integrity, professionalism, and scientific responsibility. The Editorial Board reserves the right to reject content that violates these principles.